AT257042B - Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenie bei Tieren, insbesondere Katzen und Nerzen - Google Patents

Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenie bei Tieren, insbesondere Katzen und Nerzen

Info

Publication number
AT257042B
AT257042B AT943163A AT943163A AT257042B AT 257042 B AT257042 B AT 257042B AT 943163 A AT943163 A AT 943163A AT 943163 A AT943163 A AT 943163A AT 257042 B AT257042 B AT 257042B
Authority
AT
Austria
Prior art keywords
panleucopenia
mink
animals
preparation
vaccine against
Prior art date
Application number
AT943163A
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of AT257042B publication Critical patent/AT257042B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14351—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT943163A 1962-11-27 1963-11-25 Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenie bei Tieren, insbesondere Katzen und Nerzen AT257042B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US240408A US3293130A (en) 1962-11-27 1962-11-27 Panleukopenia vaccine and method for the production thereof

Publications (1)

Publication Number Publication Date
AT257042B true AT257042B (de) 1967-09-25

Family

ID=22906395

Family Applications (2)

Application Number Title Priority Date Filing Date
AT429965A AT248793B (de) 1962-11-27 1963-11-25 Verfahren zum Immunisieren von Katzen oder Nerzen gegen Panleucopenie
AT943163A AT257042B (de) 1962-11-27 1963-11-25 Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenie bei Tieren, insbesondere Katzen und Nerzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT429965A AT248793B (de) 1962-11-27 1963-11-25 Verfahren zum Immunisieren von Katzen oder Nerzen gegen Panleucopenie

Country Status (13)

Country Link
US (1) US3293130A (de)
AT (2) AT248793B (de)
BE (1) BE640495A (de)
BR (1) BR6354820D0 (de)
CH (1) CH469093A (de)
DE (1) DE1198489B (de)
DK (1) DK104899C (de)
ES (1) ES293828A1 (de)
FI (1) FI40922B (de)
FR (1) FR1587309A (de)
GB (1) GB1071922A (de)
NL (2) NL145903B (de)
SE (1) SE334437B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3346456A (en) * 1964-07-01 1967-10-10 Cornell Res Foundation Inc Immunizing pigs against hog cholera with selected strains of live virus diarrhea virus and preparation of virus diarrhea virus hyper-immune hog cholera serum
US4021302A (en) * 1966-02-18 1977-05-03 Burroughs Wellcome & Co., Inc. Cell cultures
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
EP0011864B1 (de) * 1978-11-30 1982-05-19 The Wellcome Foundation Limited Abgeschwächter Stamm des bei Feliden infektiöse Peritonitis verursachenden Virus, Verfahren zu seiner Herstellung und ihn enthaltender Impfstoff
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same

Also Published As

Publication number Publication date
DK104899C (da) 1966-07-18
FR1587309A (de) 1970-03-20
BR6354820D0 (pt) 1973-08-02
GB1071922A (en) 1967-06-14
ES293828A1 (es) 1964-02-16
AT248793B (de) 1966-08-10
FI40922B (de) 1969-03-31
DE1198489B (de) 1965-08-12
NL300960A (de)
US3293130A (en) 1966-12-20
CH469093A (de) 1969-02-28
BE640495A (de) 1964-05-27
SE334437B (de) 1971-04-26
NL145903B (nl) 1975-05-15

Similar Documents

Publication Publication Date Title
CH479535A (de) Verfahren zur Herstellung von a-Alkyl-l-adamantanmethylaminen und a-Alkyl-3-tricyclo(4,3,1,1 3,8)undecanmethylaminen
CH433333A (de) Verfahren zur Herstellung eines neuen Amins
AT257042B (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenie bei Tieren, insbesondere Katzen und Nerzen
AT287196B (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Mastitis
AT251599B (de) Verfahren zur Herstellung von neuen 2-Guanidinoalkyl-1,4-benzodioxanen
CH439749A (de) Verfahren zur Herstellung von wässrigem Copolymer-Latex
CH451148A (de) Verfahren zur Herstellung von neuen tertiären Aminen
AT251764B (de) Verfahren zur Herstellung von neuen 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
AT283811B (de) Verfahren zur Herstellung eines stabilen Stimulans für das Wachstrum und die Entwicklung von Tieren, insbesondere Geflügel
AT252561B (de) Verfahren zur Herstellung von wässerigen Polymerdispersionen
AT239399B (de) Verfahren zur Herstellung von neuen wasserunlöslichen Monoazofarbstoffen
AT235257B (de) Verfahren zur Herstellung von Β, Β'-Dicyandiäthyläther
AT241468B (de) Verfahren zur Herstellung von neuen 1, 4-Bis- {[7'-chlorchinolyl-(4')]-aminoalkyl }-piperazinen
AT250953B (de) Verfahren zur Herstellung von neuen tertiärer Carbamyltriazole
AT247362B (de) Verfahren zur Herstellung von neuem N-Methyl-2,2-diphenyl-3-hydroxypropylcarbamat
CH430704A (de) Verfahren zur Herstellung von 4,7-Dihalogen-1-methylindan-3-onen
CH444158A (de) Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
CH491898A (de) Verfahren zur Herstellung eines 3-Keto-4,6-bisdehydro-9B,10a-steroids
AT248445B (de) Verfahren zur Herstellung von neuen 1, 2-Dimehtylhexahydropyridazinen
CH416653A (de) Verfahren zur Herstellung von 2-Methyl-3-o-äthylphenyl-4-oxo-3,4-dihydro-chinazolin
CH420158A (de) Verfahren zur Herstellung von neuen Benzothiazolen und Benzoxazolen
AT243393B (de) Verfahren zur Herstellung von neuen wasserunlöslichen Monoazofarbstoffen
CH414647A (de) Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids
AT249823B (de) Verfahren zur Herstellung neuer wasserunlöslicher 4-Nitro-4'-dialkylamino-1,1'-azobenzole
AT249220B (de) Verfahren zur Herstellung neuer wasserunlöslicher 4-Nitro-4'-dialkylamino-1,1'-azobenzole